First vaping-associated illness confirmed in N.L.

The province’s chief medical officer of health is confirming a probable case of vaping-associated lung illness in Newfoundland and Labrador.

“The emergence of vaping-associated lung illness is quite concerning, and we will continue to monitor for cases,” Dr. Janice Fitzgerald stated in a news release.

“To reduce your risk of this illness, we recommend that you do not vape any products. If you vape or smoke and wish to quit, please see your health care provider for advice on safe and effective ways to do so.”

The person affected became ill in late 2019, was hospitalized and has since recovered, the release stated.

The substance of concern is a cannabis product, which was not available for further testing, the Department of Health said.

Because of health privacy laws, no other details are being released about the case.

To date in Canada, there have been 16 confirmed or probable cases of vaping-associated lung illnesses, the department said.

While the person affected in Newfoundland and Labrador used a cannabis product, others affected across the country have used nicotine vaping products or flavour-only vaping products.

Vaping can expose people to harmful chemicals, and the longterm health effects are unknown, the department said, adding it’s not recommended for youth, pregnant women or non-smokers.

Given the concerns about vaping-associated lung illness, and the limited overall understanding of the short- and long-term health risks, the safest approach for people who use cannabis is to avoid smoking or vaping cannabis extracts, the department said.

It also said not to modify vaping products or add any substances not intended by the manufacturer.

“I am worried about the increase of vaping in Newfoundland and Labrador and its popularity with youth," Health Minister John Haggie stated. "Vaping is a significant public health concern. If you don’t already smoke, don’t vape.”